Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001410578-24-001278
Filing Date
2024-08-09
Accepted
2024-08-09 17:06:07
Documents
72
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q nwbo-20240630x10q.htm   iXBRL 10-Q 2321471
2 EX-31.1 nwbo-20240630xex31d1.htm EX-31.1 11158
3 EX-32.1 nwbo-20240630xex32d1.htm EX-32.1 8004
  Complete submission text file 0001410578-24-001278.txt   10446001

Data Files

Seq Description Document Type Size
4 EX-101.SCH nwbo-20240630.xsd EX-101.SCH 74532
5 EX-101.CAL nwbo-20240630_cal.xml EX-101.CAL 56395
6 EX-101.DEF nwbo-20240630_def.xml EX-101.DEF 333580
7 EX-101.LAB nwbo-20240630_lab.xml EX-101.LAB 521850
8 EX-101.PRE nwbo-20240630_pre.xml EX-101.PRE 461045
75 EXTRACTED XBRL INSTANCE DOCUMENT nwbo-20240630x10q_htm.xml XML 2151988
Mailing Address 4800 MONTGOMERY LANE SUITE 800 BETHESDA MD 20814
Business Address 4800 MONTGOMERY LANE SUITE 800 BETHESDA MD 20814 (240) 497-9024
NORTHWEST BIOTHERAPEUTICS INC (Filer) CIK: 0001072379 (see all company filings)

EIN.: 943306718 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35737 | Film No.: 241193890
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)